Dr. Xavier Montalban, head of the Clinical Neuroimmunology group at Vall d’Hebron Institute of Research (VHIR) and director of the Multiple Sclerosis Center in Catalonia (Cemcat), explains in a report "http://www.lavanguardia.com/salud/20130426/54371558885/mejora-terapia-esclerosis-multiple.html" published on Friday in "http://www.lavanguardia.com/salud/20130426/54371558885/mejora-terapia-esclerosis-multiple.html" La Vanguardia the last advances in the research in multiple sclerosis (MS).After more than 20 years leading research in this neurodegenerative disease, Dr. Montalban assures to the Spanish newspaper that “it is a great time for those who research and treat multiple sclerosis”. The cure of MS is not possible yet, but “perspectives are much better than one or two years ago”, thanks to the research in new therapies which reduce the outbreaks and slow down the progress of the disorder. Besides, in the following months, two new drugs will be launched in order to personalize the treatments and make them more effective and less aggressive for patients. Nonetheless, as Dr. Montalban alerts in the report, there is still a long way to identify the myelin protein which is attacked by the immune system, to define the proper treatment and, the most important, to find the cure of this disorder that in Spain affect nearly 46,000 people, according to the Spanish association of multiple sclerosis.